Considering that these and other studies have shown that ZEB1 contributes to tumor aggressiveness through EMT-dependent and independent mechanisms [18], it would be interesting to determine if SPARC, through integrin αvβ3 and ZEB1, regulates other important aspects of tumor progression, such as the generation of cell populations with CSC phenotypes or therapy resistance. This evidence concerns the gene ZEB1 and neoplasm.